Browsing Tag
Loxo Oncology
4 posts
How Eli Lilly’s $1bn SiteOne deal strengthens its bid to lead in non-opioid pain therapies
Eli Lilly to acquire SiteOne Therapeutics for up to $1B, betting on STC-004 to redefine non-opioid pain treatment. Read why investors and analysts are watching.
Lilly bags Retevmo FDA approval for RET-driven lung and thyroid cancers
Retevmo FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug…
Eli Lilly completes $8bn acquisition of Loxo Oncology to expand oncology portfolio
Eli Lilly and Company, the US-based pharmaceutical giant, has finalised its $8 billion acquisition of Connecticut-based biopharmaceutical firm…
Lilly to acquire Loxo Oncology in $8bn deal: A game-changer in precision cancer treatment
Eli Lilly and Company (Lilly), a global leader in pharmaceuticals, has made headlines with its announcement to acquire…